Cargando…
Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
Despite screening, effective anti-viral drugs and risk-balanced prophylaxis, cytomegalovirus (CMV) remains a major cause of morbidity in transplant patients. The objective of this study was to retrospectively analyze the risk factors associated with CMV viremia after kidney transplantation in a larg...
Autores principales: | Jehn, Ulrich, Schütte-Nütgen, Katharina, Bautz, Joachim, Pavenstädt, Hermann, Suwelack, Barbara, Thölking, Gerold, Heinzow, Hauke, Reuter, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019428/ https://www.ncbi.nlm.nih.gov/pubmed/31963515 http://dx.doi.org/10.3390/jcm9010252 |
Ejemplares similares
-
Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020) -
The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2021) -
Antihypertensive Treatment in Kidney Transplant Recipients—A Current Single Center Experience
por: Jehn, Ulrich, et al.
Publicado: (2020) -
Prognostic Value of Growth Differentiation Factor 15 in Kidney Donors and Recipients
por: Jehn, Ulrich, et al.
Publicado: (2020) -
A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
por: Thölking, Gerold, et al.
Publicado: (2019)